AdAlta (ASX:1AD) EPS (Diluted): A$-0.01 (TTM As of Dec. 2025)


What is AdAlta EPS (Diluted)?

AdAlta ASX:1AD EPS (Diluted) is A$-0.01 as of Dec. 2025. The stock has 2 warning signs investors should review.

AdAlta's Earnings per Share (Diluted) for the six months ended in Dec. 2025 was A$-0.00. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was A$-0.01.

AdAlta's EPS (Basic) for the six months ended in Dec. 2025 was A$-0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was A$-0.01.

AdAlta's EPS without NRI for the six months ended in Dec. 2025 was A$-0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was A$-0.01.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

AdAlta  (ASX:1AD) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

AdAlta EPS (Diluted) Related Terms

AdAlta EPS (Diluted) Historical Data

* Premium members only.

The historical data trend for AdAlta's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AdAlta EPS (Diluted) Chart

AdAlta Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only -0.02 -0.02 -0.01 -0.01 -0.01

AdAlta Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.00 -0.00 -0.00 -0.00

ASX:1AD vs VRTX, REGN, ALNY: EPS (Diluted) Comparison

For the Biotechnology subindustry, AdAlta's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AdAlta PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AdAlta's PE Ratio distribution charts can be found below:

* The bar in red indicates where AdAlta's PE Ratio falls into.


AdAlta EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

AdAlta's Diluted EPS for the fiscal year that ended in Jun. 2025 is calculated as

Diluted EPS (A: Jun. 2025 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-4.502-0)/653.077
=-0.01

AdAlta's Diluted EPS for the quarter that ended in Dec. 2025 is calculated as

Diluted EPS (Q: Dec. 2025 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-2.437-0)/1564.496
=-0.00

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Diluted) →
What does a EPS (Diluted) of A$-0.01 mean?
AdAlta (ASX:1AD) has a EPS (Diluted) of A$-0.01 as of Dec. 2025. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on AdAlta and its competitors.
Is AdAlta's EPS (Diluted) too high?
AdAlta's current EPS (Diluted) is A$-0.01.
How does AdAlta's EPS (Diluted) compare to VRTX and REGN?
AdAlta's EPS (Diluted) of A$-0.01 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Diluted) for a Biotechnology company?
A good EPS (Diluted) depends on the Biotechnology industry context. However, EPS (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Diluted) mean?
A high EPS (Diluted) can signal that a stock is expensive relative to its fundamentals. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on AdAlta and its competitors. AdAlta's current EPS (Diluted) is A$-0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AdAlta stock overvalued right now?
AdAlta (ASX:1AD) has a current EPS (Diluted) of A$-0.01. The current EPS (Diluted) is A$-0.01. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Diluted) calculated?
EPS (Diluted) is calculated from a company's financial statements. For AdAlta (ASX:1AD), the current EPS (Diluted) is A$-0.01 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

AdAlta Business Description

Address 697 Burke Road, Suite 201, Camberwell, VIC, AUS, 3124
AdAlta Ltd is engaged in drug discovery and developing protein therapeutics, known as i-bodies, for treating a wide range of human diseases. The principal business of AdAlta is the discovery and development of next-generation cells and protein based therapeutics. The i-body candidate, AD-214, is being developed for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases. Its pipeline includes Fibrosis and CAR-T cancer therapeutics.